- Home
- ALAR vs ONCY Comparison
ALAR vs ONCY Comparison
Compare ALAR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- ONCY
- Stock Information
- Founded
- ALAR 2013
- ONCY 1998
- Country
- ALAR Israel
- ONCY Canada
- Employees
- ALAR N/A
- ONCY N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- ONCY Pharmaceuticals and Biotechnology
- Sector
- ALAR Technology
- ONCY Health Care
- Exchange
- ALAR Nasdaq
- ONCY Nasdaq
- Market Cap
- ALAR 116.1M
- ONCY 89.7M
- IPO Year
- ALAR 2018
- ONCY 1999
- Fundamental
- Price
- ALAR $15.11
- ONCY $1.04
- Analyst Decision
- ALAR Strong Buy
- ONCY Strong Buy
- Analyst Count
- ALAR 1
- ONCY 5
- Target Price
- ALAR $27.00
- ONCY $5.00
- AVG Volume (30 Days)
- ALAR 130.9K
- ONCY 687.7K
- Earning Date
- ALAR 08-28-2025
- ONCY 08-08-2025
- Dividend Yield
- ALAR N/A
- ONCY N/A
- EPS Growth
- ALAR N/A
- ONCY N/A
- EPS
- ALAR 0.07
- ONCY N/A
- Revenue
- ALAR $30,488,000.00
- ONCY N/A
- Revenue This Year
- ALAR $11.54
- ONCY N/A
- Revenue Next Year
- ALAR $19.42
- ONCY N/A
- P/E Ratio
- ALAR $21.54
- ONCY N/A
- Revenue Growth
- ALAR N/A
- ONCY N/A
- 52 Week Low
- ALAR $5.45
- ONCY $0.33
- 52 Week High
- ALAR $21.50
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- ALAR 51.27
- ONCY 53.61
- Support Level
- ALAR $14.19
- ONCY $0.95
- Resistance Level
- ALAR $18.00
- ONCY $1.15
- Average True Range (ATR)
- ALAR 1.16
- ONCY 0.09
- MACD
- ALAR -0.23
- ONCY 0.01
- Stochastic Oscillator
- ALAR 24.15
- ONCY 65.62
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.